FDA Drug Application (020936) for PAXIL CR by APOTEX TECHNOLOGIES

Back to FDA Applications sponsored by APOTEX TECHNOLOGIES

Application Number020936
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
DosageEQ 12.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NamePAXIL CR
Active IngredientPAROXETINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient PAROXETINE HYDROCHLORIDE4


Back to FDA Applications sponsored by APOTEX TECHNOLOGIES